🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the proportion of hyperlipaemic persons with known coronary heart ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00442897
Treatments Being Tested
Data on the real-world use and effectiveness and safety of bempedoic acid c...
Status
Recruiting
Location
Innere Medizin
Start Date
2025-02-12
Trial ID
NCT06686615
Treatments Being Tested
A randomized open-label, multiple dose, three-treatment, three-period, six-...
Status
Completed
Location
ChongKunDang
Start Date
2014-11
Trial ID
NCT02288338
The primary purpose of this study is to evaluate the long-term safety and t...
Status
Completed
Location
Multiple Locations
Start Date
2000-10-25
Trial ID
NCT03885921
Treatments Being Tested
Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but...
Status
Recruiting
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2024-03-22
Trial ID
NCT04968509
Treatments Being Tested
The first event of the atherosclerotic plaque formation is the accumulation...
Status
Unknown
Location
Chungnam National University Hospital
Start Date
2009-07
Trial ID
NCT00952770
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047683
Treatments Being Tested
A Cohort Study for Comparison of Statin Monotherapy and Rosuzet Tab.(Rosuva...
Status
Completed
Location
Hanmi Pharmaceutical Company Limited
Start Date
2016-06-14
Trial ID
NCT04829149
Treatments Being Tested
This study was designed to assess whether co-administration of ezetimibe 10...
Status
Completed
Location
Multiple Locations
Start Date
2003-09-01
Trial ID
NCT00653796
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 1560027
Start Date
2016-07-27
Trial ID
NCT02715726